Rational design and in vitro and in vivo delivery of Dicer substrate siRNA
- PMID: 17406276
- DOI: 10.1038/nprot.2006.72
Rational design and in vitro and in vivo delivery of Dicer substrate siRNA
Abstract
RNA interference is a powerful tool for target-specific knockdown of gene expression. The triggers for this process are duplex small interfering RNAs (siRNAs) of 21-25 nt with 2-bp 3' overhangs produced in cells by the RNase III family member Dicer. We have observed that short RNAs that are long enough to serve as Dicer substrates (D-siRNA) can often evoke more potent RNA interference than the corresponding 21-nt siRNAs; this is probably a consequence of the physical handoff of the Dicer-produced siRNAs to the RNA-induced silencing complex. Here we describe the design parameters for D-siRNAs and a protocol for in vitro and in vivo intraperitoneal delivery of D-siRNAs and siRNAs to macrophages. siRNA delivery and transfection and analysis of macrophages in vivo can be accomplished within 36 h.
Similar articles
-
Principles of Dicer substrate (D-siRNA) design and function.Methods Mol Biol. 2008;442:3-10. doi: 10.1007/978-1-59745-191-8_1. Methods Mol Biol. 2008. PMID: 18369774
-
Recombinant Dicer efficiently converts large dsRNAs into siRNAs suitable for gene silencing.Nat Biotechnol. 2003 Mar;21(3):324-8. doi: 10.1038/nbt792. Epub 2003 Feb 18. Nat Biotechnol. 2003. PMID: 12592410
-
Use of microarrays in transfection of mammalian cells with dicer-digested small interfering RNAs.Anal Biochem. 2008 Mar 15;374(2):417-22. doi: 10.1016/j.ab.2007.12.029. Epub 2007 Dec 31. Anal Biochem. 2008. PMID: 18201542
-
Gene silencing through RNA interference (RNAi) in vivo: strategies based on the direct application of siRNAs.J Biotechnol. 2006 Jun 25;124(1):12-25. doi: 10.1016/j.jbiotec.2005.12.003. Epub 2006 Jan 18. J Biotechnol. 2006. PMID: 16413079 Review.
-
The Argonautes.Cold Spring Harb Symp Quant Biol. 2006;71:67-72. doi: 10.1101/sqb.2006.71.048. Cold Spring Harb Symp Quant Biol. 2006. PMID: 17381282 Review.
Cited by
-
RNA inhibition highlights cyclin D1 as a potential therapeutic target for mantle cell lymphoma.PLoS One. 2012;7(8):e43343. doi: 10.1371/journal.pone.0043343. Epub 2012 Aug 14. PLoS One. 2012. PMID: 22905260 Free PMC article.
-
Combination siRNA therapy against feline coronavirus can delay the emergence of antiviral resistance in vitro.Vet Microbiol. 2015 Mar 23;176(1-2):10-8. doi: 10.1016/j.vetmic.2014.12.009. Epub 2014 Dec 19. Vet Microbiol. 2015. PMID: 25596968 Free PMC article.
-
MicroRNA Processing and Human Cancer.J Clin Med. 2015 Aug 21;4(8):1651-67. doi: 10.3390/jcm4081651. J Clin Med. 2015. PMID: 26308063 Free PMC article. Review.
-
Supramolecular self-assembled nanoparticles mediate oral delivery of therapeutic TNF-α siRNA against systemic inflammation.Angew Chem Int Ed Engl. 2013 May 27;52(22):5757-61. doi: 10.1002/anie.201209991. Epub 2013 Apr 22. Angew Chem Int Ed Engl. 2013. PMID: 23610013 Free PMC article. No abstract available.
-
Progress toward in vivo use of siRNAs-II.Mol Ther. 2012 Mar;20(3):483-512. doi: 10.1038/mt.2011.263. Epub 2011 Dec 20. Mol Ther. 2012. PMID: 22186795 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials